Digene CEO departing
This article was originally published in The Gray Sheet
Executive Summary
Firm announces upcoming retirement of co-founder and CEO Evan Jones June 8. Having been at the helm for 16 years - from the company's inception through commercialization of its hc2 High-Risk HPV DNA Test, which has captured about 17% of the U.S. cervical cancer screening market - Jones will continue to serve as a board member...